Literature DB >> 18260757

Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004.

Adriana S Lopez1, Andrea Burnett-Hartman, Ram Nambiar, Linda Ritz, Patricia Owens, Vladimir N Loparev, Dalya Guris, D Scott Schmid.   

Abstract

We investigated a small outbreak of varicella in a long-term-care facility after a case of herpes zoster. Clinical specimens and environmental samples were collected from all case patients and from surfaces in the case patients' rooms and other common-use areas. Wild-type varicella-zoster virus (VZV) DNA was identified in all 3 varicella case patients, and high concentrations of VZV DNA were detected in environmental samples from the room of the herpes zoster case patient. Genotypic analysis showed that the identical VZV strain was present in all samples; moreover, the strain was a unique Mosaic genotype isolate that included a stable Oka vaccine marker that had hitherto never been observed in a wild-type strain of VZV. This study provides evidence for the value of including environmental sampling during the investigation of varicella outbreaks and illustrates the importance of evaluating multiple vaccine-associated markers for the discrimination of vaccine virus from wild-type VZV.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18260757     DOI: 10.1086/527419

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

1.  Clinical pearls in infectious diseases.

Authors:  Robert Orenstein; Scott C Litin
Journal:  Mayo Clin Proc       Date:  2010-02       Impact factor: 7.616

2.  Presentation and management of herpes zoster (shingles) in the geriatric population.

Authors:  Kenneth R Cohen; Rebecca L Salbu; Jerry Frank; Igor Israel
Journal:  P T       Date:  2013-04

3.  Revisiting the genotyping scheme for varicella-zoster viruses based on whole-genome comparisons.

Authors:  Nancy J Jensen; Pierre Rivailler; Hung Fu Tseng; Mark L Quinlivan; Kay Radford; Jennifer Folster; Rafael Harpaz; Philip LaRussa; Steven Jacobsen; D Scott Schmid
Journal:  J Gen Virol       Date:  2017-06-14       Impact factor: 3.891

4.  Comparison of surface sampling methods for virus recovery from fomites.

Authors:  Timothy R Julian; Francisco J Tamayo; James O Leckie; Alexandria B Boehm
Journal:  Appl Environ Microbiol       Date:  2011-08-05       Impact factor: 4.792

5.  Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zoster.

Authors:  Mark L Quinlivan; Nancy J Jensen; Kay W Radford; D Scott Schmid
Journal:  J Clin Microbiol       Date:  2012-02-29       Impact factor: 5.948

6.  Seroprevalence survey for Varicella among healthcare workers and medical students in Italy.

Authors:  Ottavia Balbi; Savino Baldi; Stefano Rizza; Antonio Pietroiusti; Stefano Perrone; Luca Coppeta
Journal:  Hum Vaccin Immunother       Date:  2020-07-09       Impact factor: 3.452

7.  Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine.

Authors:  Barbara A Pahud; Carol A Glaser; Cornelia L Dekker; Ann M Arvin; D Scott Schmid
Journal:  J Infect Dis       Date:  2010-12-21       Impact factor: 5.226

Review 8.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

Review 9.  Clinical practice: Herpes zoster.

Authors:  Jeffrey I Cohen
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245

Review 10.  A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24-25 July 2008.

Authors:  Judith Breuer; Charles Grose; Peter Norberg; Graham Tipples; D Scott Schmid
Journal:  J Gen Virol       Date:  2010-01-13       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.